Eli Lilly (LLY) rated 91/100 OVR on MarketMVP. Eli Lilly's Mounjaro and Zepbound obesity drugs represent a generational product cycle. Demand substantially exceeds sup. Tier: S-Tier (Elite). Revenue: +36%. Beta: 0.65.
Using the MarketMVP OVR system — which translates stocks into sports player ratings for intuitive comparison — LLY scores 91/100 OVR (S-Tier (Elite)). The three dimensions: Momentum (80/100) reflects recent price and fundamental trends. Stability (85/100) measures earnings consistency and volatility profile. Value (50/100) assesses price relative to fundamentals and sector peers.
LLY is compared to different athletes depending on which sport lens you use — but the archetype is consistent: Season MVP.
What does Eli Lilly (LLY) do?
Eli Lilly (LLY) rated 91/100 OVR on MarketMVP. Eli Lilly's Mounjaro and Zepbound obesity drugs represent a generational product cycle. Demand substantially exceeds sup. Tier: S-Tier (Elite). Revenue: +36%. Beta: 0.65.
What sector is LLY in?
LLY is classified in the Healthcare sector on MarketMVP. Healthcare companies develop pharmaceuticals, medical devices, and health services.
Is LLY in the S&P 500?
LLY (Eli Lilly) is a component of the S&P 500 index. The S&P 500 includes the 500 largest US-listed companies by market capitalisation. Inclusion generally indicates a company has met size, liquidity, and profitability criteria.
Who are LLY's main competitors?
Eli Lilly's main competitors include NVO, PFE, ABBV, BMY. In the Healthcare sector, competition is assessed on market share, technology differentiation, pricing power, and customer retention rates.
Is LLY overvalued?
LLY has a P/E ratio of 48x and a value score of 50/100 on MarketMVP. A mid-range value score suggests the stock is neither obviously cheap nor obviously expensive relative to fundamentals. Valuation is always relative to growth rate and sector context.
What is LLY's P/E ratio?
LLY's P/E ratio is 48x. The S&P 500 average P/E ratio is approximately 22x — a P/E above this indicates a growth premium. MarketMVP's value score of 50/100 contextualises this P/E against revenue growth and sector peers.
What is LLY's market cap?
Eli Lilly (LLY) has a market capitalisation of approximately $740B. Market cap above $200B is considered large-cap — generally more stable with lower volatility. Market cap equals the current share price multiplied by the total number of shares outstanding.
How volatile is LLY stock?
LLY has a beta of 0.65, which MarketMVP calls the 'Injury Risk Rating'. Beta below 1.0 means the stock moves less than the market — relatively defensive in downturns. Stability score: 85/100.
What is LLY's beta?
LLY's beta is 0.65. Beta measures how much a stock moves relative to the overall market. A beta of 0.65 means that historically, for every 1% the market moves, LLY tends to move approximately 0.65%. Lower beta indicates a more defensive investment that reacts less to market swings.
What is LLY's dividend?
LLY pays a dividend with an approximate yield of 0.6%. Dividend-paying stocks return a portion of profits to shareholders each quarter. The yield represents the annual dividend as a percentage of the stock price.
What is LLY's revenue growth?
Eli Lilly reported revenue growth of +36% year-over-year. Revenue growth above 20% is exceptional — typically associated with high-growth technology or healthcare companies in expanding markets.
What is LLY's OVR rating on MarketMVP?
LLY is rated 91/100 OVR on MarketMVP — placing it in S-Tier (Elite). The OVR score combines three dimensions: Momentum (80/100), Stability (85/100), and Value (50/100). Think of it like a FIFA or NBA 2K player rating — a 96 OVR is generational, 80-89 is strong, 65-79 is solid rotation, below 65 is speculative.
Which athlete is LLY most like?
On MarketMVP, LLY is compared to different athletes depending on your sport: NFL → Patrick Mahomes, NBA → Giannis Antetokounmpo, Soccer → Erling Haaland. The archetype is 'Season MVP' — Eli Lilly (LLY) rated 91/100 OVR on MarketMVP. Eli Lilly's Mounjaro and Zepbound obesity drugs repre
What percentage of a portfolio should be in LLY?
Position sizing depends on conviction, risk tolerance, and portfolio construction philosophy. As a general framework: S-Tier stocks like LLY might represent 5-8% of a balanced portfolio if held as a core anchor position. No position sizing recommendation is universal — it depends on your complete portfolio context.
Is LLY a long-term investment?
Eli Lilly has a track record of consistent earnings and a wide competitive moat that has held up over multiple business cycles. Long-term holding suitability depends on whether you believe the competitive position will remain intact over your investment horizon.
What happens to LLY stock in a recession?
In economic downturns, LLY's performance would depend on its business characteristics. Stability score of 85/100 and beta of 0.65 suggests relatively defensive behaviour — revenue from Healthcare tends to hold up better than cyclical sectors.
How does LLY compare to the S&P 500?
LLY has a MarketMVP OVR of 91/100 which places it in S-Tier — the highest-rated category on the platform. Revenue growth of +36% compares to the S&P 500 average of approximately 7-10% annually. Beta of 0.65 compares to the S&P 500 beta of 1.0 — less volatile.
What is LLY's price target?
MarketMVP does not publish specific price targets — we are an educational platform, not a financial advisory service. Price targets are published by institutional analysts at investment banks and appear on financial platforms like Bloomberg, Yahoo Finance, and MarketBeat. Our OVR system rates LLY at 91/100 (S-Tier (Elite)) based on fundamental characteristics rather than price prediction.
What are analysts saying about LLY?
MarketMVP provides an educational OVR rating of 91/100 for LLY. For professional analyst ratings and price targets, consult platforms like Bloomberg, Yahoo Finance, Seeking Alpha, or your brokerage's research section. MarketMVP's role is to translate financial characteristics into sports-analogous metrics, not to provide investment advice.
What is LLY's revenue?
Eli Lilly reported year-over-year revenue growth of +36%. Market capitalisation of $740B provides context for the revenue multiple. For specific revenue figures, quarterly earnings reports (10-Q filings) and annual reports (10-K filings) are publicly available on the SEC EDGAR database and the company's investor relations website.
Does LLY pay a dividend?
LLY pays a dividend. The approximate current yield is 0.6%. Dividend payments are typically made quarterly. The dividend yield represents annual payments as a percentage of the current stock price.